| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |